Head Positioning May Not Be Key to Acute Stroke Outcome

Share this content:
Head Positioning May Not Be Key to Acute Stroke Outcome
Head Positioning May Not Be Key to Acute Stroke Outcome

THURSDAY, June 22, 2017 (HealthDay News) -- Head positioning does not appear to affect survival and recovery in acute ischemic stroke patients, according to a study published in the June 22 issue of the New England Journal of Medicine.

Craig Anderson, M.D., Ph.D., head of the George Institute for Global Health China at the Peking University Health Science Center in Beijing, and colleagues randomly assigned hospitals in nine countries to treat 11,093 patients with acute stroke in one of two ways for the first 24 hours. Those in one group were told to lie on their backs, while the other was allowed to sit up with head elevated at least 30 degrees.

Patients in the lying-flat group were less likely to maintain the position for 24 hours than patients in the sitting-up group (87 versus 95 percent). After 90 days, researchers found no significant differences in mortality rates and disability between the two groups. Nor was there any significant difference in the rate of complications like pneumonia.

"In conclusion, the lying-flat head position, as compared to the sitting-up position, initiated early after presentation and maintained for 24 hours, did not alter disability outcomes in patients with acute stroke," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths